de Coppi, Paolo;
Loukogeorgakis, Stavros;
Götherström, Cecilia;
David, Anna L;
Almeida-Porada, Graça;
Chan, Jerry KY;
Deprest, Jan;
... Tam, Paul Kwong Hang; + view all
(2022)
Regenerative medicine: prenatal approaches.
The Lancet Child and Adolescent Health
, 6
(9)
pp. 643-653.
10.1016/S2352-4642(22)00192-4.
Preview |
Text
David_RM Prenatal Revision SPL 08.04.22 PT(Clean Copy).pdf Download (684kB) | Preview |
Abstract
This two-paper Series focuses on recent advances and applications of regenerative medicine that could benefit paediatric patients. Innovations in genomic, stem-cell, and tissue-based technologies have created progress in disease modelling and new therapies for congenital and incurable paediatric diseases. Prenatal approaches present unique opportunities associated with substantial biotechnical, medical, and ethical obstacles. Maternal plasma fetal DNA analysis is increasingly adopted as a noninvasive prenatal screening or diagnostic test for chromosomal and monogenic disorders. The molecular basis for cell-free DNA detection stimulated the development of circulating tumour DNA testing for adult cancers. In-utero stem-cell, gene, gene-modified cell (and to a lesser extent, tissue-based) therapies have shown early clinical promise in a wide range of paediatric disorders. Fetal cells for postnatal treatment and artificial placenta for ex-utero fetal therapies are new frontiers in this exciting field.
Archive Staff Only
 |
View Item |
